EBOO

EBOO or Extracorporeal Blood Oxygenation and Ozonation is unique hemofiltration like procedure developed and now used routinely at the medical departments at the University of Sienna in Italy.

EBOO combines modern membrane dialysis used to treat heart, kidney and liver failure with ozone therapy, historically a popular alternative therapy in mainland Europe the evidence base for which has long been questioned by western medicine. Extensive testing of EBOO has revealed no toxicity or side effects in sheep or human volunteers.

A clinical trial of EBOO showed it to be more effective in the treatment of Peripheral artery disease than Prostacyclin. . Further trials are currently underway for heart disease and stroke patients for whom preliminary reports of ozone treatment have been postive.

Clinical trials of Celacade another blood ozonation treatment have report similar benefits in chronic heart failure.

EBOO is also reported to have remedied necrotizing fasciitis, an often fatal bacterial infection resistant to antibiotics. Ozones anti-bacterial and viral properties have been employed successfully in water purification. The International Society of Blood Purification has recognized EBOO as warranting clinical investigation as a viral load reducing treatment.